Translation initiation factor 4E (eIF4E) is regulated by cell death inhibitor, Diap1

被引:0
|
作者
Lee, Sun Kyung
Lee, Ji Sun
Shin, Ki Soon
Yoo, Soon Ji [1 ]
机构
[1] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea
关键词
cap-dependent translation; Diap1; eIF4E; oncogenic transformation; regulation of protein synthesis; ubiquitination;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Translation initiation factor 4E (eIF4E) is a key regulator of protein synthesis. Abnormal regulation of eIF4E is closely linked to oncogenic transformation. Several regulatory mechanisms affecting eIF4E are discussed, including transcriptional regulation, phosphorylation and binding of an inhibitor protein. However it is not clear how the level of eIF4E protein is regulated under basal conditions. Here we demonstrate that Diap1 (Drosophila Inhibitor of Apoptosis Protein), a cell death inhibitor, binds directly to eIF4E and poly-ubiquitinates it via its E3 ligase activity, promoting its proteasome-dependent degradation. Expression of Diap1 caused a reduction of Cyclin D1 protein level and inhibited the growth stimulation induced by overexpression of eIF4E. Taken together, our results suggest that the level of eIF4E protein is regulated by Diap1, and that IAPs may play a role in capdependent translation by regulating the level of eIF4E protein.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [1] Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
    Hsieh, Andrew C.
    Ruggero, Davide
    CLINICAL CANCER RESEARCH, 2010, 16 (20) : 4914 - 4920
  • [2] The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer
    Karaki, Sara
    Andrieu, Claudia
    Ziouziou, Hajer
    Rocchi, Palma
    ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101, 2015, 101 : 1 - 26
  • [3] Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer
    O'Rourke, Rachel L.
    Garner, Amanda L.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025, 8 (03) : 621 - 635
  • [4] TARGETING THE EUKARYOTIC TRANSLATION INITIATION FACTOR 4E (EIF4E) FOR CANCER THERAPY
    Graff, Jeremy R.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3300 - 3300
  • [5] The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
    Amorim, Ines S.
    Lach, Gilliard
    Gkogkas, Christos G.
    FRONTIERS IN GENETICS, 2018, 9
  • [6] Translation Initiation Factor 4E (eIF4E): Prognostic Marker and Potential Therapeutic Target
    Meric-Bernstam, Funda
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 2996 - 2997
  • [7] Translation Initiation Factor 4E (eIF4E): Prognostic Marker and Potential Therapeutic Target
    Funda Meric-Bernstam
    Annals of Surgical Oncology, 2008, 15 : 2996 - 2997
  • [8] Elevated eukaryotic translation initiation factor 4E (eIF4E) is involved in erlotinib resistance
    Li, Yikun
    Koo, Junghui
    Fan, Songqing
    Yue, Ping
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    Sun, Shi-Yon
    CANCER RESEARCH, 2011, 71
  • [9] Homeodomain proteins and eukaryotic translation initiation factor 4E (eIF4E): an unexpected relationship
    Topisirovic, I
    Borden, KLB
    HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (04) : 1275 - 1284
  • [10] Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer
    Salehi, Z
    Mashayekhi, F
    CLINICAL BIOCHEMISTRY, 2006, 39 (04) : 404 - 409